UFCSPA Porto Alegre's bAIgrapher, created by Area 23 in 2024, uses generative AI to preserve memories for Alzheimer's patients, winning a Clio Health Silver
ARCHIVEHow UFCSPA Porto Alegre and Area 23 Turned AI Into an Alzheimer's Memory Tool
bAIgrapher is a 2024 documentary-style social experiment campaign created by Area 23, an IPG Health company, for Brazilian medical institution UFCSPA Porto Alegre, published in January 2024 in the United States, in which a generative-AI platform produces personalised biographies drawn from stories supplied by people living with Alzheimer's disease and their relatives, functioning as a reminiscence-therapy tool designed to stimulate memory and support meaningful interactions with loved ones.
The campaign sits at the intersection of healthcare innovation and emotional narrative. Area 23 conceived the original bAIgrapher concept as early as 2019 as an AI-powered instrument to help Alzheimer's patients preserve life memories, and UFCSPA Porto Alegre joined the project in a research and clinical-validation capacity rather than as the originating advertiser. That long development arc — from internal idea to internationally recognised campaign — gives bAIgrapher an unusual depth for a healthcare advertising entry. A controlled clinical trial involving 240 subjects at UFCSPA was scheduled as part of the project's validation pathway, according to reporting cited by The One Club, underscoring that the work moves beyond conceptual advertising into applied medical research.
In the United States, where Alzheimer's disease affects an enormous and growing patient population, the campaign targets both healthcare professionals and lay audiences. Its documentary and social experiment format signals transparency and intellectual rigour — qualities that resonate with the discerning audiences the health industry must win over. The Clapboard Score for bAIgrapher is 63 out of 100, reflecting strong conceptual ambition and meaningful award validation tempered by limited public engagement metrics at the time of evaluation. The campaign earned a Silver Award at Clio Health 2024 and a Bronze Pencil at The One Show 2024 in the Craft — Data-Driven Personalization category, as documented by The Clio Awards and oneclub.org respectively, confirming its standing as one of the more rigorously judged healthcare entries of the year.
ARCHIVEArea 23 grounded bAIgrapher in a precise and underserved insight. Reminiscence therapy — the structured use of autobiographical memory to improve emotional wellbeing in dementia patients — is a clinically recognised intervention, yet the tools available to practitioners and families have historically been analogue, labour-intensive, and inconsistently personalised. By deploying a generative-AI platform to automate and scale biography creation, Area 23 translated a therapeutic methodology into a technology product, then wrapped that product inside a documentary-format campaign capable of reaching audiences in the United States and beyond.
The strategic context for this move is significant. U.S. healthcare and pharmaceutical media spending was projected to exceed thirty billion dollars in 2024, growing approximately five percent year over year, according to intelligencebank.com. Digital channels were expected to continue gaining share through 2026, even as healthcare advertisers maintained an unusually high reliance on linear television, radio, and print compared with other industries, per the same source. bAIgrapher's digital-first, film-led format positions it squarely within the growth corridor of that media landscape.
In terms of institutional reputation, UFCSPA Porto Alegre competes for credibility in the United States against organisations including Mayo Clinic and Johns Hopkins Medicine — institutions with decades of brand equity built on research authority and clinical excellence. The bAIgrapher campaign addresses that competitive gap not by claiming clinical equivalence but by demonstrating methodological innovation: a Brazilian medical school partnering with a New York-based IPG Health agency to produce a tool that prestigious North American institutions have not yet publicly deployed. That positioning is strategically astute. Rather than contesting established reputational hierarchies on their own terms, the campaign stakes new ground in AI-assisted patient care, where the competitive landscape remains genuinely open and where a credible clinical trial — 240 subjects at UFCSPA, as reported via oneclub.org — lends the work scientific legitimacy that advertising alone cannot manufacture.
bAIgrapher takes the form of a documentary and social experiment, a genre choice that carries specific creative consequences. Documentary framing demands observed reality over constructed narrative, which means the campaign's emotional power depends on the authenticity of its subjects — people living with Alzheimer's disease and the family members who share their stories with the AI platform. Area 23's creative team made the AI's output visible within the film, allowing audiences to witness biography generation as it happens rather than simply asserting that the technology works.
The production involved a collaboration of specialist partners. According to oneclub.org, WideLabs, Ritmika Audio Arts, and Lado provided additional creative contributions to the campaign, indicating a multi-studio production model consistent with the technical and sonic ambitions of a film designed to carry emotional weight in a healthcare context. The AI model development underpinning the tool was a core component of the craft, as the generative system had to produce biographies sensitive enough in tone and accurate enough in detail to function as genuine reminiscence-therapy instruments rather than novelty outputs.
The decision to enter the campaign in the Craft — Data-Driven Personalization category at The One Show, where it won a Bronze Pencil as documented by oneclub.org, reflects Area 23's confidence in the technical construction of the work. Data-driven personalization in a healthcare setting is a demanding standard: the personalisation must be clinically plausible, emotionally resonant, and ethically defensible. The campaign also won Gold in the Print and Out-of-Home Campaign of the Year — Providers and Insurers category at the 2023 Healthcare Marketing Impact Awards, as reported by smithandjones.com and openpr.com, demonstrating that its creative reach extended across multiple formats and jury constituencies. Full directorial and chief creative officer credits for bAIgrapher are not comprehensively documented in publicly available sources at the time of writing.
Verified public engagement data for bAIgrapher is limited. The campaign asset recorded 404 views at the time of evaluation, a figure that reflects the controlled, industry-facing distribution strategy typical of healthcare campaigns navigating regulatory sensitivities in the United States rather than a consumer-broadcast media buy. No independent third-party reach or conversion metrics are publicly available for this campaign.
The award record, however, constitutes a substantive performance signal in its own right. bAIgrapher won a Silver Award at Clio Health 2024, categorised under Health Institutions and Services, Innovation, and Digital Product Innovation, as documented by clios.com. It won a Bronze Pencil at The One Show 2024 in the Craft — Data-Driven Personalization category, per oneclub.org. It also won Gold at the 2023 Healthcare Marketing Impact Awards in the Print and Out-of-Home Campaign of the Year — Providers and Insurers category, as reported by smithandjones.com and openpr.com. Three substantive jury validations across three distinct award bodies, each with independent evaluation criteria, constitutes meaningful evidence of executional and conceptual quality.
Structurally, bAIgrapher's effectiveness rests on its dual function: it operates simultaneously as an advertising campaign and as a clinical tool scheduled for trial validation. That dual utility makes the work unusually durable. Most healthcare advertising campaigns exhaust their value once the media cycle closes. bAIgrapher retains ongoing relevance as long as the clinical trial at UFCSPA progresses, creating a self-renewing narrative for UFCSPA Porto Alegre and Area 23 in the United States market. The Clapboard Score of 63 out of 100 reflects this balance — strong foundational concept and credible award standing, with room to grow as clinical and engagement data accumulates.
bAIgrapher is a 2024 healthcare campaign created by Area 23 for UFCSPA Porto Alegre. It uses a generative-AI platform to produce personalised biographies from stories told by Alzheimer's patients and their relatives, functioning as a reminiscence-therapy tool. The campaign was published in the United States in January 2024 and won multiple industry awards.
bAIgrapher won a Silver Award at Clio Health 2024 in the Health Institutions and Services, Innovation, and Digital Product Innovation categories, as documented by clios.com. It also won a Bronze Pencil at The One Show 2024 in the Craft — Data-Driven Personalization category, per oneclub.org, confirming recognition across two major healthcare advertising juries.
Area 23, an IPG Health company based in New York, created bAIgrapher. The agency reportedly conceived the original idea in 2019 as an AI tool to help Alzheimer's patients preserve life memories, according to sources cited by oneclub.org. The campaign was formally published in the United States in January 2024, representing a five-year development journey from concept to launch.
bAIgrapher uses a generative-AI platform that takes stories supplied by people living with Alzheimer's disease and their relatives and transforms them into personalised biographies. The tool is designed as a reminiscence-therapy instrument to stimulate memory recall and support interactions with loved ones, and a controlled clinical trial involving 240 subjects at UFCSPA was scheduled for validation.
bAIgrapher holds a Clapboard Score of 63 out of 100, as assessed by Clapboard's editorial team. The score reflects strong conceptual ambition and credible multi-award validation across Clio Health, The One Show, and the Healthcare Marketing Impact Awards, balanced against limited publicly available engagement metrics at the time of evaluation in the United States market.
bAIgrapher involved multiple specialist production contributors alongside lead agency Area 23. According to oneclub.org, WideLabs, Ritmika Audio Arts, and Lado provided additional creative credits on the campaign. These partners contributed to the film's technical and sonic construction, supporting the documentary-format execution that helped the campaign achieve recognition across healthcare advertising juries in 2024.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
.jpg&w=256&q=75)
